{
  "abstract": "Phosphaturic mesenchymal tumours (PMTs) are rare fibroblast growth factor-23 producing lesions presenting clinically as cases of osteomalacia. Non-specific symptoms and a varied histological appearance often lead to misdiagnosis, delayed treatment and prolonged morbidity for the patient. We report a case of a patient in his late forties presenting with generalised body ache, weakness and difficulty in walking for 3 years. Biochemical investigations revealed an increased renal phosphate wasting, with functional imaging showing a somatostatin receptor-expressing lesion in the distal epiphysis of the left tibia. A CT scan was done to precisely locate the tumour which was then resected en bloc. The patient was managed postoperatively with oral phosphate and vitamin D supplementation, which saw him recover completely at 1-year follow-up. Guidelines for diagnosis and treatment of PMTs need to be established to streamline the management of this condition.",
  "authors": [
    {
      "affiliations": [
        "Orthopedics, St John’s Medical College Hospital, Bangalore, Karnataka, India"
      ],
      "name": "Jasjeet Singh"
    },
    {
      "affiliations": [
        "Orthopedics, St John’s Medical College Hospital, Bangalore, Karnataka, India"
      ],
      "name": "Monish Nachu"
    },
    {
      "affiliations": [
        "Orthopedics, St John’s Medical College Hospital, Bangalore, Karnataka, India"
      ],
      "name": "Rajagopal Honnasandra Prabhakar"
    }
  ],
  "title": "Tumour-induced osteomalacia: a diagnostic conundrum",
  "uid": "46e82aec-b2e8-5e09-91e4-3b7a39435ea8"
}